Literature DB >> 11435321

Acquired pure red cell aplasia associated with lymphoproliferative disease of granular T lymphocytes.

R S Go1, C Y Li, A Tefferi, R L Phyliky.   

Abstract

Acquired pure red cell aplasia (PRCA) can be associated with lymphoproliferative disease of granular T lymphocytes (T-LDGL), also known as T-cell large granular lymphocyte leukemia. Fifteen adult patients with PRCA associated with T-LDGL comprise this study. Neutropenia and rheumatoid arthritis were uncommon. All patients responded to immunosuppressive therapy. The 2 most commonly used treatments were prednisone and cyclophosphamide +/- corticosteroids, producing overall response rates of 50% and 60%, respectively. Treatment with cyclophosphamide was associated with a more durable remission (median, 60 versus 7.5 months). After a median follow-up of 67 months, 2 patients died of treatment-related complications, one from myelodysplasia and another from cyclosporine-induced renal failure. The clinical course and treatment responses of PRCA associated with T-LDGL in this series were similar to the general group of PRCA. Because T-LDGL is frequently underdiagnosed, it is likely that a significant proportion of idiopathic or primary PRCA is in fact secondary to T-LDGL.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11435321     DOI: 10.1182/blood.v98.2.483

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  26 in total

Review 1.  Anemia of Central Origin.

Authors:  Kazusa Ishii; Neal S Young
Journal:  Semin Hematol       Date:  2015-07-09       Impact factor: 3.851

2.  High frequency of autonomous T-cell proliferation compatible with T-cell large granular lymphocytic leukemia in patients with cytopenia of unknown etiology.

Authors:  Ozlen Bektas; Aysegul Uner; Seda Muruvvet Aydin; Eylem Eliacik; Burak Uz; Ayse Işık; Ibrahim Celalettin Haznedaroğlu; Hakan Goker; Nilgun Sayinalp; Salih Aksu; Halûk Demiroglu; Osman Ilhami Ozcebe; Yahya Buyukasik
Journal:  Int J Hematol       Date:  2015-05-26       Impact factor: 2.490

3.  Age-associated alteration of γδ T-cell repertoire and different profiles of activation-induced death of Vδ1 and Vδ2 T cells.

Authors:  Yoshihiro Michishita; Makoto Hirokawa; Yong-Mei Guo; Yukiko Abe; Jiajia Liu; Kumi Ubukawa; Naohito Fujishima; Masumi Fujishima; Tomoko Yoshioka; Yoshihiro Kameoka; Hirobumi Saito; Hiroyuki Tagawa; Naoto Takahashi; Kenichi Sawada
Journal:  Int J Hematol       Date:  2011-08-20       Impact factor: 2.490

Review 4.  The pathogenesis and treatment of large granular lymphocyte leukemia.

Authors:  Steven Nathaniel Steinway; Francis LeBlanc; Thomas P Loughran
Journal:  Blood Rev       Date:  2014-03-07       Impact factor: 8.250

Review 5.  Immune pathophysiology of aplastic anemia.

Authors:  Jaroslaw P Maciejewski; Antonio Risitano; Hoon Kook; Weihua Zeng; Guibin Chen; Neal S Young
Journal:  Int J Hematol       Date:  2002-08       Impact factor: 2.490

6.  How I treat LGL leukemia.

Authors:  Thierry Lamy; Thomas P Loughran
Journal:  Blood       Date:  2010-12-29       Impact factor: 22.113

7.  Analysis of a French cohort of patients with large granular lymphocyte leukemia: a report on 229 cases.

Authors:  Benoît Bareau; Jérôme Rey; Mohamed Hamidou; Jean Donadieu; Jeff Morcet; Oumedaly Reman; Nicolas Schleinitz; Olivier Tournilhac; Mikael Roussel; Thierry Fest; Thierry Lamy
Journal:  Haematologica       Date:  2010-04-07       Impact factor: 9.941

8.  MICA polymorphism identified by whole genome array associated with NKG2D-mediated cytotoxicity in T-cell large granular lymphocyte leukemia.

Authors:  Aaron D Viny; Michael J Clemente; Monika Jasek; Medhat Askar; Hemant Ishwaran; Amy Nowacki; Aiwen Zhang; Jaroslaw P Maciejewski
Journal:  Haematologica       Date:  2010-05-11       Impact factor: 9.941

Review 9.  Peripheral T-cell lymphoma.

Authors:  Wing Y Au; Raymond Liang
Journal:  Curr Oncol Rep       Date:  2002-09       Impact factor: 5.075

Review 10.  The root of many evils: indolent large granular lymphocyte leukaemia and associated disorders.

Authors:  Ranran Zhang; Mithun Vinod Shah; Thomas P Loughran
Journal:  Hematol Oncol       Date:  2010-09       Impact factor: 5.271

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.